Abdullatif Al‐Khal

3.9k total citations
50 papers, 656 citations indexed

About

Abdullatif Al‐Khal is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Abdullatif Al‐Khal has authored 50 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 14 papers in Epidemiology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Abdullatif Al‐Khal's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (9 papers) and Vaccine Coverage and Hesitancy (6 papers). Abdullatif Al‐Khal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (9 papers) and Vaccine Coverage and Hesitancy (6 papers). Abdullatif Al‐Khal collaborates with scholars based in Qatar, United States and Jordan. Abdullatif Al‐Khal's co-authors include Abdülbari Bener, Shuja Reagu, Majid Alabdulla, Roland M. Jones, Muna Almaslamani, Hadi M. Yassine, Hussam Al Soub, Carma L. Bylund, Laith J. Abu‐Raddad and Peter Coyle and has published in prestigious journals such as JAMA, Nature Communications and PLoS ONE.

In The Last Decade

Abdullatif Al‐Khal

42 papers receiving 627 citations

Peers

Abdullatif Al‐Khal
Abdullatif Al‐Khal
Citations per year, relative to Abdullatif Al‐Khal Abdullatif Al‐Khal (= 1×) peers Garba Iliyasu

Countries citing papers authored by Abdullatif Al‐Khal

Since Specialization
Citations

This map shows the geographic impact of Abdullatif Al‐Khal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullatif Al‐Khal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullatif Al‐Khal more than expected).

Fields of papers citing papers by Abdullatif Al‐Khal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullatif Al‐Khal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullatif Al‐Khal. The network helps show where Abdullatif Al‐Khal may publish in the future.

Co-authorship network of co-authors of Abdullatif Al‐Khal

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullatif Al‐Khal. A scholar is included among the top collaborators of Abdullatif Al‐Khal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullatif Al‐Khal. Abdullatif Al‐Khal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chemaitelly, Hiam, Naveed Akhtar, Saadat Kamran, et al.. (2025). Incidence of stroke following COVID-19 vaccination: a nationwide self‑controlled risk interval study in Qatar. Expert Review of Vaccines. 24(1). 1101–1110.
2.
Ibrahim, Emad, et al.. (2025). Recurrent Vulvovaginal Candidiasis Caused by Fluconazole-Resistant Candida albicans: A Retrospective Study. Cureus. 17(2). e78906–e78906. 1 indexed citations
3.
Maslamani, Muna Al, Abdullatif Al‐Khal, Mas Chaponda, et al.. (2025). A Cluster of Meningococcal Serogroup W135 Infections: A Case Series. Cureus. 17(3). e80747–e80747.
4.
Nafady‐Hego, Hanaa, Zain A. Bhutta, Muna Almaslamani, et al.. (2024). Gastrointestinal illness among attendees of the FIFA Football World Cup 2022 in Qatar. IJID Regions. 14. 100493–100493. 1 indexed citations
5.
Shah, Brijen J., et al.. (2024). Addressing Citations in an ACGME-I Psychiatry Residency Program: From Probationary to Continued Accreditation Within 13 Months. Journal of Graduate Medical Education. 16(1). 11–14.
6.
Al‐Khal, Abdullatif, et al.. (2024). Etiology of bronchiectasis in Qatar: A retrospective study. Qatar medical journal. 2024(2). 23–23.
7.
Butt, Adeel A., Hanaa Nafady‐Hego, Zain A. Bhutta, et al.. (2024). Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar. Clinical Epidemiology and Global Health. 30. 101843–101843. 1 indexed citations
8.
Chemaitelly, Hiam, Naveed Akhtar, Saadat Kamran, et al.. (2024). Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar. International Journal of Infectious Diseases. 145. 107095–107095. 1 indexed citations
9.
Soltani, Abderrezzaq, et al.. (2024). Health professionals’ views and experiences of breaking bad news in the Eastern Mediterranean Region: a scoping review. Frontiers in Medicine. 11. 1440867–1440867.
10.
Ahmad, Fareed, Majid Alam, Ahmed Zaqout, et al.. (2024). Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy. Reviews in Medical Virology. 34(5). e2578–e2578. 2 indexed citations
11.
Butt, Adeel A., et al.. (2023). Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar. Nature Communications. 14(1). 24–24. 3 indexed citations
12.
Butt, Adeel A., Anvar Hassan Kaleeckal, Ali Nizar Latif, et al.. (2023). Immediate and contributory causes of death in patients hospitalized with COVID-19. International Journal of Infectious Diseases. 132. 4–8. 1 indexed citations
13.
Chemaitelly, Hiam, Sawsan AlMukdad, Zaina Al Kanaani, et al.. (2023). All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic. BMJ Global Health. 8(5). e012291–e012291. 7 indexed citations
14.
Ibrahim, Mohamed Izham Mohamed, et al.. (2022). Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study. PLoS ONE. 17(5). e0267884–e0267884. 7 indexed citations
15.
Alabdulla, Majid, et al.. (2021). COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population. Influenza and Other Respiratory Viruses. 15(3). 361–370. 119 indexed citations
16.
Soub, Hussam Al, et al.. (2021). Middle East respiratory syndrome coronavirus infection profile in Qatar: An 8-year experience. IDCases. 24. e01161–e01161. 4 indexed citations
17.
Mir, Fayaz Ahmad, Abdullatif Al‐Khal, Muna Al Maslamani, et al.. (2021). Molecular characteristics of Neisseria meningitidis in Qatar. Scientific Reports. 11(1). 4812–4812. 4 indexed citations
18.
Al-Khatib, Hebah A., Fatiha M. Benslimane, Peter Coyle, et al.. (2020). Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities. Frontiers in Cellular and Infection Microbiology. 10. 575613–575613. 50 indexed citations
19.
Almaslamani, Muna, et al.. (2018). Pseudomonas aeruginosa bacteremia in ICU; clinical presentation and outcome, emergence of MDR strains. Journal of Antivirals & Antiretrovirals. 2(1). 3–7. 3 indexed citations
20.
Al‐Badriyeh, Daoud, et al.. (2015). Statin Selection in Qatar Based on Multi-indication Pharmacotherapeutic Multi-criteria Scoring Model, and Clinician Preference. Clinical Therapeutics. 37(12). 2798–2810. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026